What is the effect of Testosterone Replacement Therapy (TRT) on fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effect of Testosterone Replacement Therapy (TRT) on Fertility

Testosterone Replacement Therapy significantly suppresses fertility in men and should not be prescribed to men who are currently trying to conceive or wish to preserve their fertility potential. 1

Mechanism of TRT Impact on Fertility

Exogenous testosterone therapy affects male fertility through several key mechanisms:

  • Provides negative feedback to the hypothalamus and pituitary gland
  • Inhibits gonadotropin secretion (FSH and LH)
  • Suppresses intratesticular testosterone production essential for spermatogenesis
  • Results in oligospermia or azoospermia in most men 1

Timeline of Fertility Effects

  • Initial impact: Sperm production begins declining shortly after starting TRT
  • Complete effect: Most men develop significant oligospermia or azoospermia within 3-6 months of starting therapy
  • Recovery period: After discontinuing TRT, recovery of sperm to the ejaculate typically takes 3-6 months but can take up to years in some cases 1, 2

Risk Factors for Prolonged Recovery

  • Longer duration of TRT use
  • Higher doses of testosterone
  • Older age
  • Pre-existing testicular conditions
  • Combined use with other anabolic steroids 2

Fertility Preservation Options Before Starting TRT

For men considering TRT who wish to preserve fertility potential:

  • Sperm banking/cryopreservation before initiating therapy is strongly recommended 1
  • Fertility counseling should be provided to all men of reproductive age before starting TRT 3

Alternative Treatments for Hypogonadal Men Desiring Fertility

Men with hypogonadism who wish to maintain fertility should consider:

  1. Human Chorionic Gonadotropin (hCG) therapy:

    • Stimulates testicular testosterone production
    • Maintains intratesticular testosterone levels
    • Preserves spermatogenesis 1, 4, 5
  2. Selective Estrogen Receptor Modulators (SERMs) like clomiphene citrate:

    • Blocks estrogen feedback at hypothalamus/pituitary
    • Increases endogenous LH and FSH production
    • Elevates testosterone while maintaining sperm production 1, 4
  3. Aromatase inhibitors:

    • Reduces conversion of testosterone to estrogen
    • Can increase testosterone levels while preserving fertility 1, 5

Monitoring and Management

For men on TRT who later desire fertility:

  1. Discontinue TRT at least 3-6 months before attempting conception
  2. Regular semen analysis to track recovery
  3. Consider adjunctive therapy with hCG, SERMs, or aromatase inhibitors if recovery is delayed
  4. Fertility specialist referral if azoospermia persists beyond 6 months after discontinuation 1, 2

Special Considerations

  • Transgender individuals undergoing gender-affirming hormone therapy face similar fertility challenges and should be counseled on fertility preservation options before starting treatment 6, 7
  • Anabolic steroid users may experience more severe and prolonged suppression of spermatogenesis requiring more aggressive intervention 2, 4

Common Pitfalls

  • Assuming fertility returns immediately after stopping TRT
  • Failing to counsel patients about fertility implications before starting therapy
  • Overlooking alternative treatments that can address hypogonadal symptoms while preserving fertility
  • Not considering sperm banking before initiating treatment in men of reproductive age

Remember that while many men will recover fertility after discontinuing TRT, some may experience permanent impairment, making pre-treatment counseling and fertility preservation critical considerations.

References

Guideline

Fertility Considerations in Men Undergoing Testosterone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Preserving fertility in the hypogonadal patient: an update.

Asian journal of andrology, 2015

Research

Reproductive capacity after gender-affirming testosterone therapy.

Human reproduction (Oxford, England), 2023

Research

Fertility concerns of the transgender patient.

Translational andrology and urology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.